Orphan Disease, Drugs, and Dentistry: A Cumulative Review

Abstract

Orphan diseases also known as rare diseases (RDs) are typically hereditary in nature. According to World Health Organization, RDs have a prevalence of 1 in 1000 individuals. Few RDs such as Turner syndrome, Synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO), Williams syndrome, neurofibromatosis type I, Gorlin–Goltz, Schimke immuno, and cherubism exhibit oral signs. The disease’s great complexity and relatively low occurrence necessitates a diagnostotherapeutic strategy based on the Integration of Several Specializations. Rare illnesses require a worldwide agreement about the planning of future interventions. Dentists are often the first medical professionals to recognize RDs because oral symptoms often appear several years before the corresponding systemic symptoms. The objective of this article is to showcase information about RDs and several activities undertaken over the past decade to address this worldwide issue.